Empresa Genscript Biotech Corporation
Acciones
1548
KYG3825B1059
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
11,02 HKD | +2,42 % | +5,56 % | -44,51 % |
Resumen de negocios
Número de empleados: 6 937
Ventas por actividad
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Life-science Services and Products
48,2
%
| 2 739 | 55,9 % | 3 167 | 48,2 % | +15,62 % |
Cell Therapy
33,9
%
| 914 | 18,6 % | 2 231 | 33,9 % | +144,18 % |
Biologics Development Services
12,7
%
| 941 | 19,2 % | 835 | 12,7 % | -11,23 % |
Industrial Synthetic Biology Products
5,1
%
| 299 | 6,1 % | 336 | 5,1 % | +12,18 % |
Operation Unit
0,1
%
| 7 | 0,1 % | 4 | 0,1 % | -42,83 % |
Ventas por región
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
60,3
%
| 2 600 | 53,1 % | 3 961 | 60,3 % | +52,32 % |
China
19,4
%
| 1 306 | 26,7 % | 1 273 | 19,4 % | -2,54 % |
Europe
11,9
%
| 417 | 8,5 % | 779 | 11,9 % | +86,73 % |
Asia Pacific (excluding China)
6,3
%
| 462 | 9,4 % | 417 | 6,3 % | -9,81 % |
Others
2,2
%
| 114 | 2,3 % | 143 | 2,2 % | +25,58 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Weihui Shao
CEO | Chief Executive Officer | - | 01/01/23 |
Ye Wang
FOU | Founder | 55 | 01/01/02 |
Shiniu Wei
DFI | Director of Finance/CFO | - | - |
Jian Ge Meng
CHM | Chairman | 55 | 01/04/10 |
Li Zhu
BRD | Director/Board Member | 74 | 01/01/10 |
Berkan Unal
PRN | Corporate Officer/Principal | - | - |
Jing Jing Hua
AUD | Comptroller/Controller/Auditor | - | - |
Wai Ling Wong
SEC | Corporate Secretary | 45 | 24/08/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Hong Xin Guo
BRD | Director/Board Member | 61 | 24/08/15 |
Li Zhu
BRD | Director/Board Member | 74 | 01/01/10 |
Xue Hai Wang
BRD | Director/Board Member | 50 | 22/11/20 |
Jia Fen Wang
BRD | Director/Board Member | 73 | 26/11/18 |
Zu Mian Dai
BRD | Director/Board Member | 47 | 24/08/15 |
Fang Liang Zhang
CEO | Chief Executive Officer | 59 | 01/01/02 |
Lu Quan Wang
FOU | Founder | 54 | 01/01/02 |
Ye Wang
FOU | Founder | 55 | 01/01/02 |
Jian Ge Meng
CHM | Chairman | 55 | 01/04/10 |
Jiu An Pan
BRD | Director/Board Member | 56 | 26/11/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 2 124 027 670 | 1 147 683 091 ( 54,03 %) | 0 | 54,03 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
LEGEND BIOTECH CORPORATION 60.32% | 174 497 556 | 60.32% | 4 893 783 958 $ |
Información de la empresa
Genscript Biotech Corp.
No. 28, Yongxi Road Jiangning Science Park
210000, Nanjing
+86 25 5889 7288
http://www.genscript.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Pharmaceuticals: Major
| |
Probio Technology Ltd. (George Town)
Probio Technology Ltd. (George Town) BiotechnologyHealth Technology Probio Technology Ltd. (Cayman Islands) is a company based in George Town, the Cayman Islands. |
Biotechnology
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-44,51 % | 2919,51 M | |
+2,02 % | 42,59 mil M | |
+7,07 % | 40,65 mil M | |
+49,17 % | 40,57 mil M | |
-11,96 % | 26,77 mil M | |
+8,48 % | 24,81 mil M | |
-23,82 % | 18,17 mil M | |
+27,21 % | 12,05 mil M | |
-3,05 % | 11,7 mil M | |
+7,10 % | 11,1 mil M |
- Bolsa de valores
- Acciones
- Acción 1548
- Empresa Genscript Biotech Corporation